Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Thinking out loud

<< Previous

Bullboard Posts

Next >>

Comment by Inthepezon Oct 01, 2022 1:50pm

119 Views

Post# 34999510

RE:RE:RE:Thinking out loud

If not mistaken this molar study will be on healthy patients. Shouldn't see any issues SE wise in acute that's not a nocebo (opposite of placebo effect)

MrMugsy wrote:

TheMadMonk wrote:
AllinATE,

Please note that while the P2 molar trial is scheduled to start this week on the 28th, Dan did mention that it could be delayed a couple days. The independent laboratory that tests and certifies the drugs to be used in the trial has been backed up and there is the chance that the start date of the trial may be delayed a few days. If that happens don't be alarmed, it was always a possibility and does not mean that there is anything wrong with ATE or the study.

Timing for the commercial study update is likely tied to P2 start and first enrollment (study pushed out as well). Since we didn't get either by Friday - highly likely we get it next week - assuming no serious delay. Let's get this show on the road !